2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$60.22+$0.20 (+0.32%)
Price as of Jul 31, 2026 7:38 PM EDT- $11.6BMarket Cap
- 3.23%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$60.22+$0.20 (+0.32%)
BMRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $60.02 | ||
Change | -$0.56 (-0.92%) | ||
Open | $60.38 | ||
High | $60.80 | ||
Low | $58.92 | ||
Previous Close | $60.58 | ||
Volume | 2,377,106 | ||
30-Day Average Volume | 1,583,642 | ||
1-Week Change | 1.16% | ||
1-Month Change | 4.89% | ||
1-Year Change | 3.23% | ||
3-Year Change | -31.74% | ||
5-Year Change | -21.78% | ||
Fundamentals | |||
Shares Outstanding | 193.3M | ||
Total Assets | $8.6B | ||
Market Cap | $11.6B | ||
Enterprise Value | $10.8B | ||
Period: QTR TTM FY | |||
Revenue | $760.1M | ||
Net Income | $105.5M | ||
Free Cash Flow | $199.7M | ||
EBIT | $150.8M | ||
EBITDA | $167.2M | ||
Net Working Capital | $3.8B | ||
EPS | $0.54 | ||
Enterprise Value/EBITDA | 65 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 2 | ||
P/E | 111 | ||
PEG | 0 | ||
Price/Free Cash Flow | 58 | ||
Price/Operating Cash Flow | 53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue